In an observational cohort study of adults living with obesity and diabetes, we found that the primary incidence of congestive heart failure was lower in patients treated with bariatric metabolic surgery than in those on first-generation GLP-1 receptor agonists, an effect that was not explained by greater weight loss in the group that received bariatric metabolic surgery.
This is a preview of subscription content, log in via an institution to check access.
References
Lauer, M. S., Anderson, K. M., Kannel, W. B. & Levy, D. The impact of obesity on left ventricular mass and geometry: the Framingham Heart Study. J. Am. Med. Assoc. 266, 231–236 (1991). This epidemiological study reports a strong association between body mass index and left ventricular hypertrophy.
Drucker, D. J. Prevention of cardiorenal complications in people with type 2 diabetes and obesity. Cell Metab. 1, S1550–s4131 (2024). This review presents evidence on the use of treatments, including GLP-1RAs and BMS, for preventing complications in people with diabetes and/or obesity.
Vorsanger, M. H. et al. Cardiovascular effects of the new weight loss agents. J. Am. Coll. Cardiol. 68, 849–859 (2016). This review article summarizes data on the effects of GLP-1RAs on major cardiovascular risk factors, including weight loss.
Henry, J. A. et al. Changes in epicardial and visceral adipose tissue depots following bariatric surgery and their effect on cardiac geometry. Front. Endocrinol. 14, 1092777 (2023). This is a serial imaging study of adipose depots and cardiac geometry after bariatric surgery in 62 patients.
Rassen, J. A., Murk, W. & Schneeweiss, S. Real-world evidence of bariatric surgery and cardiovascular benefits using electronic health records data: a lesson in bias. Diabetes Obes. Metab. 23, 1453–1462 (2021). This paper demonstrates the impact of information bias and confounding on results of the analyses of electronic health records.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This is a summary of: Wolff Sagy, Y. et al. Effectiveness of bariatric metabolic surgery versus glucagon-like peptide-1 receptor agonists for prevention of congestive heart failure. Nat. Med. https://doi.org/10.1038/s41591-024-03052-0 (2024).
Rights and permissions
About this article
Cite this article
Bariatric metabolic surgery is associated with a lower risk for heart failure versus GLP-1RAs. Nat Med (2024). https://doi.org/10.1038/s41591-024-03120-5
Published:
DOI: https://doi.org/10.1038/s41591-024-03120-5
- Springer Nature America, Inc.